amphotericin B liposomal
Selected indexed studies
- Safety and usefulness of nebulized liposomal amphotericin B: Systematic scoping review. (Pulm Pharmacol Ther, 2023) [PMID:37414132]
- Liposomal Amphotericin B (AmBisome(®)): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions. (Drugs, 2016) [PMID:26818726]
- Liposomal amphotericin B-the past. (J Antimicrob Chemother, 2022) [PMID:36426673]
_Worker-drafted node — pending editorial review._
Connections
amphotericin B liposomal is a side effect of
Sources
- Liposomal Amphotericin B (AmBisome(®)): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions. (2016) pubmed
- Safety and usefulness of nebulized liposomal amphotericin B: Systematic scoping review. (2023) pubmed
- Liposomal amphotericin B-the past. (2022) pubmed
- [Liposomal amphotericin B]. (2005) pubmed
- [Clinical safety of liposomal amphotericin B]. (2021) pubmed
- Liposomal amphotericin B: clinical experience and perspectives. (2005) pubmed
- Ambisome--liposomal amphotericin B. (1993) pubmed
- Liposomal amphotericin B treatment of Old World cutaneous and mucosal leishmaniasis: A literature review. (2018) pubmed
- Dosing implications for liposomal amphotericin B in pregnancy. (2023) pubmed
- Liposomal formulations of amphotericin B: differences according to the scientific evidence. (2015) pubmed